Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.
Angulo JC, Ciria Santos JP, Gómez-Caamaño A, Poza de Celis R, González Sala JL, García Garzón JM, Galán-Llopis JA, Pérez Sampietro M, Perrot V, Planas Morin J; ANARESISTANCE study group. Angulo JC, et al. Among authors: perez sampietro m. World J Urol. 2022 Oct;40(10):2459-2466. doi: 10.1007/s00345-022-04108-x. Epub 2022 Sep 4. World J Urol. 2022. PMID: 36057895 Free PMC article.
Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study.
Morote J, Gómez-Caamaño A, de Celis RP, Gómez-Veiga F, Ciria JP, Calleja J, Extramiana J, Pérez-Sampietro M, Perrot V, Angulo JC; ANALUTS Study Group. Morote J, et al. Among authors: perez sampietro m. Neurourol Urodyn. 2022 Nov;41(8):1824-1833. doi: 10.1002/nau.25031. Epub 2022 Sep 7. Neurourol Urodyn. 2022. PMID: 36069170 Free PMC article.
Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study.
Calleja-Escudero J, Barrondo V, Rodriguez-Alonso A, Gómez-Veiga F, Bestard J, Gómez-Caamaño A, Grandoulier AS, Pérez-Sampietro M, Chantada-Abal V, Poza de Celis R. Calleja-Escudero J, et al. Among authors: perez sampietro m. Drugs Context. 2024 Jun 19;13:2024-2-2. doi: 10.7573/dic.2024-2-2. eCollection 2024. Drugs Context. 2024. PMID: 38915919 Free PMC article.